Host and viral determinants for MxB restriction of HIV-1 infection

被引:84
作者
Matreyek, Kenneth A. [1 ,2 ]
Wang, Weifeng [1 ,2 ]
Serrao, Erik [1 ,2 ]
Singh, Parmit Kumar [3 ]
Levin, Henry L. [3 ]
Engelman, Alan [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[3] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Eukaryot Transposable Elements, Program Cellular Regulat & Metab, NIH, Bethesda, MD 20892 USA
来源
RETROVIROLOGY | 2014年 / 11卷
关键词
Innate immunity; MxB; Mx2; HIV-1; Restriction factor; HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 INTEGRASE MUTANTS; DYNAMIN-LIKE MXA; DNA INTEGRATION; ANTIVIRAL SPECIFICITY; REVERSE TRANSCRIPTION; QUANTITATIVE-ANALYSIS; NUCLEAR-ENVELOPE; EARLY STEPS; PROTEIN;
D O I
10.1186/s12977-014-0090-z
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Interferon-induced cellular proteins play important roles in the host response against viral infection. The Mx family of dynamin-like GTPases, which include MxA and MxB, target a wide variety of viruses. Despite considerable evidence demonstrating the breadth of antiviral activity of MxA, human MxB was only recently discovered to specifically inhibit lentiviruses. Here we assess both host and viral determinants that underlie MxB restriction of HIV-1 infection. Results: Heterologous expression of MxB in human osteosarcoma cells potently inhibited HIV-1 infection (similar to 12-fold), yet had little to no effect on divergent retroviruses. The anti-HIV effect manifested as a partial block in the formation of 2-long terminal repeat circle DNA and hence nuclear import, and we accordingly found evidence for an additional post-nuclear entry block. A large number of previously characterized capsid mutations, as well as mutations that abrogated integrase activity, counteracted MxB restriction. MxB expression suppressed integration into gene-enriched regions of chromosomes, similar to affects observed previously when cells were depleted for nuclear transport factors such as transportin 3. MxB activity did not require predicted GTPase active site residues or a series of unstructured loops within the stalk domain that confer functional oligomerization to related dynamin family proteins. In contrast, we observed an N-terminal stretch of residues in MxB to harbor key determinants. Protein localization conferred by a nuclear localization signal (NLS) within the N-terminal 25 residues, which was critical, was fully rescuable by a heterologous NLS. Consistent with this observation, a heterologous nuclear export sequence (NES) abolished full-length MxB activity. We additionally mapped sub-regions within amino acids 26-90 that contribute to MxB activity, finding sequences present within residues 27-50 particularly important. Conclusions: MxB inhibits HIV-1 by interfering with minimally two steps of infection, nuclear entry and post-nuclear trafficking and/or integration, without destabilizing the inherent catalytic activity of viral preintegration complexes. Putative MxB GTPase active site residues and stalk domain Loop 4 -both previously shown to be necessary for MxA function - were dispensable for MxB antiviral activity. Instead, we highlight subcellular localization and a yet-determined function(s) present in the unique MxB N-terminal region to be required for HIV-1 restriction.
引用
收藏
页数:20
相关论文
共 65 条
[1]   The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum [J].
Accola, MA ;
Huang, B ;
Al Masri, A ;
McNiven, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21829-21835
[2]  
[Anonymous], 2011, R: A Language and Environment for Statistical Computing
[3]   ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE MUTANTS [J].
ANSARILARI, MA ;
DONEHOWER, LA ;
GIBBS, RA .
VIROLOGY, 1995, 211 (01) :332-335
[4]   Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus [J].
Brussel, A ;
Sonigo, P .
JOURNAL OF VIROLOGY, 2003, 77 (18) :10119-10124
[5]   Human immunodeficiency virus type 1 nucleocapsid Zn2+ fingers are required for efficient reverse transcription, initial integration processes, an protection of newly synthesized viral DNA [J].
Buckman, JS ;
Bosche, WJ ;
Gorelick, RJ .
JOURNAL OF VIROLOGY, 2003, 77 (02) :1469-1480
[6]   Host and Viral Determinants of Mx2 Antiretroviral Activity [J].
Busnadiego, Idoia ;
Kane, Melissa ;
Rihn, Suzannah J. ;
Preugschas, Hannah F. ;
Hughes, Joseph ;
Blanco-Melo, Daniel ;
Strouvelle, Victoria P. ;
Zang, Trinity M. ;
Willett, Brian J. ;
Boutell, Chris ;
Bieniasz, Paul D. ;
Wilson, Sam J. .
JOURNAL OF VIROLOGY, 2014, 88 (14) :7738-7752
[7]   A quantitative assay for HIV DNA integration in vivo [J].
Butler, SL ;
Hansen, MST ;
Bushman, FD .
NATURE MEDICINE, 2001, 7 (05) :631-634
[8]   Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system [J].
Chang, LJ ;
Urlacher, V ;
Iwakuma, T ;
Cui, Y ;
Zucali, J .
GENE THERAPY, 1999, 6 (05) :715-728
[9]   HIV DNA Integration [J].
Craigie, Robert ;
Bushman, Frederic D. .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (07)
[10]   TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm [J].
De Iaco, Alberto ;
Santoni, Federico ;
Vannier, Anne ;
Guipponi, Michel ;
Antonarakis, Stylianos ;
Luban, Jeremy .
RETROVIROLOGY, 2013, 10